Bacterial Cybergenetics | AMR | Nemesis Bioscience

Latest News

Keep up to date with the latest news and developments from Nemisis Bioscience.

2 NEMESIS BIOSCIENCE AWARDED €2M EIC ACCELERATOR GRANT Nemesis Bioscience Ltd announced today that it has been awarded a European Innovation Council (EIC) Accelerator grant of €2 million to advance its work in the prevention of antibiotic -resistant infections. In this highly competitive process, Nemesis was one of only 74 companies funded from many thousands of applicants. In a two-year, EIC funded programme,… 18.07.2022
0 NEMESIS BIOSCIENCE ANNOUNCES THE APPOINTMENT OF DR YOSHINORI YAMANO AS NON-EXECUTIVE DIRECTOR Nemesis Bioscience Ltd announced today that it had appointed Dr Yoshinori Yamano to its board as a non-executive director. Dr Yamano is currently Chief Scientific Officer for Infectious Diseases at Shionogi & Co., Ltd. and has held several senior management positions at Shionogi since joining the company in 1986. He is an internationally renowned microbiologist… 12.07.2022
3 NEMESIS BIOSCIENCE ANNOUNCES RESEARCH COLLABORATION WITH SHIONOGI Nemesis Bioscience Ltd announced today that it had reached an agreement on terms for a two-year research collaboration with Shionogi & Co. Ltd. to further develop Nemesis Transmid Technology© for the treatment and/or prevention of hard-to-treat respiratory infections caused by Pseudomonas aeruginosa. The collaboration will leverage the innovative science and technology platforms of both parties… 06.07.2020